These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2622013)

  • 1. [Clinical significance of factor IX analysis in blood coagulation tests].
    Kakishita E; Nishida Y
    Nihon Rinsho; 1989 Dec; 48 Suppl():834-6. PubMed ID: 2622013
    [No Abstract]   [Full Text] [Related]  

  • 2. [Factor IX and factor IX inhibitor].
    Higasa S
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():647-50. PubMed ID: 15658413
    [No Abstract]   [Full Text] [Related]  

  • 3. Immune reactive factor IX in acquired factor IX deficiency.
    Lechner K
    Thromb Diath Haemorrh; 1972 Feb; 27(1):19-24. PubMed ID: 5033668
    [No Abstract]   [Full Text] [Related]  

  • 4. [Presence of inactive factor ix in variants of hemophilia, type B, and in carriers of hemophilia B].
    Elodi S
    Minerva Med; 1975 Jun; 66(42):2037-43. PubMed ID: 1138213
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: Electroimmunoassay of human coagulation factor IX in the detection of variants of haemophilia B.
    Orstavik K; Osterud B
    Thromb Diath Haemorrh; 1975 Sep; 34(1):322-3. PubMed ID: 1188733
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of APTT reagent sensitivity to factor IX and factor IX assay performance. Results from the College of American Pathologists Survey Program.
    Brandt JT; Arkin CF; Bovill EG; Rock WA; Triplett DA
    Arch Pathol Lab Med; 1990 Feb; 114(2):135-41. PubMed ID: 2405809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and clinical significance of PIVKA.
    Veltkamp JJ
    Mayo Clin Proc; 1974 Dec; 49(12):923-4. PubMed ID: 4444340
    [No Abstract]   [Full Text] [Related]  

  • 8. Performances of an artificial reagent for the one-stage factor IX assay.
    Meunier L; Allain JP; Frommel D
    Thromb Diath Haemorrh; 1975 Jun; 33(3):547-52. PubMed ID: 1154311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor IX Zutphen. A genetic variant of blood coagulation factor IX with an abnormally high molecular weight.
    Bertina RM; Van Der Linden IK
    J Lab Clin Med; 1982 Nov; 100(5):695-704. PubMed ID: 7130828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electroimmunoassay of factor IX in patients with liver damage and vitamin K unresponsive coagulation disorder.
    Girolami A; Burul A; Cappellato G; Dal Bo Zanon R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(1):65-71. PubMed ID: 88391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The comparison of CS-2500 and BCS XP coagulation analyzers for Factor VIII and Factor IX one-stage clotting assays.
    Genc S; Aydin AF; Karaca E; Ömer B
    Int J Lab Hematol; 2019 Oct; 41(5):e124-e127. PubMed ID: 31034727
    [No Abstract]   [Full Text] [Related]  

  • 12. Trypsin clotting time (K-test) in hemophilia A and in hemophilia B1.
    Girolami A; Dal Bo Zanon R; Procidano M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):863-71. PubMed ID: 6176512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple assay for human factor IX: use of canine hemophilia B plasma as substrate.
    Goldsmith JC; Chung KS; Roberts HR
    Thromb Res; 1978 Mar; 12(3):497-502. PubMed ID: 653637
    [No Abstract]   [Full Text] [Related]  

  • 14. [An unified method of one-stage quantitative analysis of factors VIII and IX. I. (Results of the studies of the working group of the All-Union Problem-Solving Commission on "Pathology of hemostasis")].
    Barkagan ZS
    Gematol Transfuziol; 1991 Apr; 36(4):33-5. PubMed ID: 1906034
    [No Abstract]   [Full Text] [Related]  

  • 15. [Thromboplastin generation test and possible errors in its reproducibility].
    Tarasova LN
    Lab Delo; 1980; (11):669-71. PubMed ID: 6160299
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical significance of factor VIII analysis in blood coagulation tests].
    Kakishita E; Nishida Y
    Nihon Rinsho; 1989 Dec; 48 Suppl():831-3. PubMed ID: 2516159
    [No Abstract]   [Full Text] [Related]  

  • 17. [Blood coagulation disorders caused by abnormal blood coagulation factors].
    Fiedler H
    Z Arztl Fortbild (Jena); 1972 Jul; 66(13):692-8. PubMed ID: 4636972
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical significance of factor VII analysis in blood coagulation tests].
    Matsumoto K; Ikematsu S
    Nihon Rinsho; 1989 Dec; 48 Suppl():828-30. PubMed ID: 2622012
    [No Abstract]   [Full Text] [Related]  

  • 19. Prosthetic heart valves and rare hypersensitivity to vitamin K antagonists resulting from factor IX mutation: how to manage anticoagulation?
    Holbro A; Marbet GA; Tran TH; Oldenburg J; Friesewinkel O; Tsakiris DA
    Haemophilia; 2010 Jan; 16(1):187-9. PubMed ID: 19804386
    [No Abstract]   [Full Text] [Related]  

  • 20. Coagulation factor IX in normal and haemophilia B plasma.
    Somer JB; Castaldi PA
    Br J Haematol; 1970 Feb; 18(2):147-59. PubMed ID: 5439522
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.